C. Perou, T. Sorlie, M. Eisen, M. Van-de-rijn, S. Jeffrey et al., Molecular portraits of human breast tumours, Nature, vol.406, issue.6797, pp.747-752, 2000.
DOI : 10.1038/35021093

T. Sorlie, R. Tibshirani, J. Parker, T. Hastie, J. Marron et al., Repeated observation of breast tumor subtypes in independent gene expression data sets, Proceedings of the National Academy of Sciences, vol.100, issue.14, pp.8418-8423, 2003.
DOI : 10.1073/pnas.0932692100

P. Bedard, A. Hansen, M. Ratain, and L. Siu, Tumour heterogeneity in the clinic, Nature, vol.31, issue.7467, pp.355-364, 2013.
DOI : 10.1038/nature12627

A. Marusyk, D. Tabassum, P. Altrock, V. Almendro, F. Michor et al., Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity, Nature, vol.25, issue.7520, pp.54-58, 2014.
DOI : 10.1038/nature13556

M. Junttila and F. De-sauvage, Influence of tumour micro-environment heterogeneity on therapeutic response, Nature, vol.37, issue.7467, pp.346-354, 2013.
DOI : 10.1038/nature12626

O. Garner and L. Baum, Galectin???glycan lattices regulate cell-surface glycoprotein organization and signalling: Table 1, Biochemical Society Transactions, vol.36, issue.6, pp.1472-1477, 2008.
DOI : 10.1042/BST0361472

M. Vladoiu, M. Labrie, and Y. St-pierre, Intracellular galectins in cancer cells: potential new targets for therapy (Review)
URL : https://hal.archives-ouvertes.fr/pasteur-01137339

G. Levi and V. Teichberg, Isolation and physicochemical characterization of electrolectin, a beta-D-galactoside binding lectin from the electric organ of Electrophorus electricus, J Biol Chem, vol.256, pp.5735-5740, 1981.

S. Barondes, V. Castronovo, D. Cooper, R. Cummings, K. Drickamer et al., Galectins: A family of animal ??-galactoside-binding lectins, Cell, vol.76, issue.4, pp.597-598, 1994.
DOI : 10.1016/0092-8674(94)90498-7

F. Liu and G. Rabinovich, Galectins as modulators of tumour progression, Nature Reviews Cancer, vol.19, issue.1, pp.29-41, 2005.
DOI : 10.1038/nrc1275

N. Than, R. Romero, M. Goodman, A. Weckle, J. Xing et al., A primate subfamily of galectins expressed at the maternal-fetal interface that promote immune cell death, Proceedings of the National Academy of Sciences, vol.106, issue.24, pp.9731-9736, 2009.
DOI : 10.1073/pnas.0903568106

N. Demotte, R. Bigirimana, G. Wieers, V. Stroobant, J. Squifflet et al., A Short Treatment with Galactomannan GM-CT-01 Corrects the Functions of Freshly Isolated Human Tumor-Infiltrating Lymphocytes, Clinical Cancer Research, vol.20, issue.7, pp.1823-1833, 2014.
DOI : 10.1158/1078-0432.CCR-13-2459

J. Cerliani, T. Dalotto-moreno, D. Compagno, L. Dergan-dylon, D. Laderach et al., Study of Galectins in Tumor Immunity: Strategies and Methods, Methods Mol Biol, vol.1207, pp.249-268, 2015.
DOI : 10.1007/978-1-4939-1396-1_16

S. Madden, C. Clarke, P. Gaule, S. Aherne, O. Donovan et al., BreastMark: An Integrated Approach to Mining Publicly Available Transcriptomic Datasets Relating to Breast Cancer Outcome, Breast Cancer Research, vol.116, issue.Suppl 3, p.52, 2013.
DOI : 10.1007/s10549-008-0183-2

J. Parker, M. Mullins, M. Cheang, S. Leung, D. Voduc et al., Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes, Journal of Clinical Oncology, vol.27, issue.8, pp.1160-1167, 2009.
DOI : 10.1200/JCO.2008.18.1370

E. Jung, H. Moon, B. Cho, C. Jeong, Y. Joo et al., Galectin-1 expression in cancer-associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer, International Journal of Cancer, vol.7, issue.11, pp.2331-2338, 2007.
DOI : 10.1002/ijc.22434

Z. Hu, C. Fan, D. Oh, J. Marron, X. He et al., The molecular portraits of breast tumors are conserved across microarray platforms, BMC Genomics, vol.7, issue.1, p.96, 2006.
DOI : 10.1186/1471-2164-7-96

M. Uhlen, P. Oksvold, L. Fagerberg, E. Lundberg, K. Jonasson et al., Towards a knowledge-based Human Protein Atlas, Nature Biotechnology, vol.9, issue.12, pp.1248-1250, 2010.
DOI : 10.1038/msb.2009.93

M. Uhlen, L. Fagerberg, B. Hallstrom, C. Lindskog, P. Oksvold et al., Tissue-based map of the human proteome, Science, vol.347, issue.6220, p.1260419, 2015.
DOI : 10.1126/science.1260419

M. Demers, A. Rose, A. Grosset, K. Biron-pain, L. Gaboury et al., Overexpression of Galectin-7, A Myoepithelial Cell Marker, Enhances Spontaneous Metastasis of Breast Cancer Cells, The American Journal of Pathology, vol.176, issue.6, pp.3023-3031, 2010.
DOI : 10.2353/ajpath.2010.090876
URL : https://hal.archives-ouvertes.fr/pasteur-00819591

Y. Takenaka, T. Fukumori, T. Yoshii, N. Oka, H. Inohara et al., Nuclear Export of Phosphorylated Galectin-3 Regulates Its Antiapoptotic Activity in Response to Chemotherapeutic Drugs, Molecular and Cellular Biology, vol.24, issue.10, pp.4395-4406, 2004.
DOI : 10.1128/MCB.24.10.4395-4406.2004

C. Boileau, F. Poirier, J. Pelletier, M. Guevremont, N. Duval et al., Intracellular localisation of galectin-3 has a protective role in chondrocyte survival, Annals of the Rheumatic Diseases, vol.67, issue.2, pp.175-181, 2008.
DOI : 10.1136/ard.2006.066514

G. Finak, N. Bertos, F. Pepin, S. Sadekova, M. Souleimanova et al., Stromal gene expression predicts clinical outcome in breast cancer, Nature Medicine, vol.25, issue.5, pp.518-527, 2008.
DOI : 10.1038/nm1764

P. Farmer, H. Bonnefoi, P. Anderle, D. Cameron, P. Wirapati et al., A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer, Nature Medicine, vol.57, issue.1, pp.68-74, 2009.
DOI : 10.1186/bcr1608

U. Jeschke, D. Mayr, B. Schiessl, I. Mylonas, S. Schulze et al., Expression of Galectin-1, -3 (gal-1, gal-3) and the Thomsen???Friedenreich (TF) Antigen in Normal, IUGR, Preeclamptic and HELLP Placentas, Placenta, vol.28, issue.11-12, pp.1165-1173, 2007.
DOI : 10.1016/j.placenta.2007.06.006

G. Barrientos, N. Freitag, I. Tirado-gonzalez, L. Unverdorben, U. Jeschke et al., Involvement of galectin-1 in reproduction: past, present and future, Human Reproduction Update, vol.20, issue.2, pp.175-193, 2014.
DOI : 10.1093/humupd/dmt040

U. Jeschke, S. Hutter, S. Heublein, T. Vrekoussis, U. Andergassen et al., Expression and function of galectins in the endometrium and at the human feto-maternal interface, Placenta, vol.34, issue.10, pp.863-872, 2013.
DOI : 10.1016/j.placenta.2013.07.005

E. Miko, M. Meggyes, B. Bogar, N. Schmitz, A. Barakonyi et al., Involvement of Galectin-9/TIM-3 Pathway in the Systemic Inflammatory Response in Early-Onset Preeclampsia, PLoS ONE, vol.1950, issue.8, p.71811, 2013.
DOI : 10.1371/journal.pone.0071811.g003

G. Rabinovich and M. Toscano, Turning 'sweet' on immunity: galectin???glycan interactions in immune tolerance and inflammation, Nature Reviews Immunology, vol.16, issue.5, pp.338-352, 2009.
DOI : 10.1038/nri2536

N. Perillo, K. Pace, J. Seilhamer, and L. Baum, Apoptosis of T cells mediated by galectin-1, Nature, vol.119, issue.6558, pp.736-739, 1995.
DOI : 10.1038/378736a0

N. Rubinstein, M. Alvarez, N. Zwirner, M. Toscano, J. Ilarregui et al., Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection, Cancer Cell, vol.5, issue.3, pp.241-251, 2004.
DOI : 10.1016/S1535-6108(04)00024-8

B. Stillman, D. Hsu, M. Pang, C. Brewer, P. Johnson et al., Galectin-3 and Galectin-1 Bind Distinct Cell Surface Glycoprotein Receptors to Induce T Cell Death, The Journal of Immunology, vol.176, issue.2, pp.778-789, 2006.
DOI : 10.4049/jimmunol.176.2.778

P. Juszczynski, J. Ouyang, S. Monti, S. Rodig, K. Takeyama et al., The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma, Proceedings of the National Academy of Sciences, vol.104, issue.32, pp.13134-13139, 2007.
DOI : 10.1073/pnas.0706017104

F. Cedeno-laurent, M. Opperman, S. Barthel, V. Kuchroo, and C. Dimitroff, Galectin-1 Triggers an Immunoregulatory Signature in Th Cells Functionally Defined by IL-10 Expression, The Journal of Immunology, vol.188, issue.7, pp.3127-3137, 2012.
DOI : 10.4049/jimmunol.1103433

E. Parco, I. Gendronneau, G. Dang, T. Delacour, D. Thijssen et al., Genetic assessment of the importance of galectin-3 in cancer initiation, progression, and dissemination in mice, Glycobiology, vol.19, issue.1, pp.68-75, 2009.
DOI : 10.1093/glycob/cwn105
URL : https://hal.archives-ouvertes.fr/hal-00332592

D. Laderach, L. Gentilini, L. Giribaldi, V. Delgado, L. Nugnes et al., A Unique Galectin Signature in Human Prostate Cancer Progression Suggests Galectin-1 as a Key Target for Treatment of Advanced Disease, Cancer Research, vol.73, issue.1, pp.86-96, 2013.
DOI : 10.1158/0008-5472.CAN-12-1260

A. Danguy, S. Rorive, C. Decaestecker, Y. Bronckart, H. Kaltner et al., Immunohistochemical profile of galectin-8 expression in benign and malignant tumors of epithelial, mesenchymatous and adipous origins, and of the nervous system, Histol Histopathol, vol.16, pp.861-868, 2001.

Y. Levy, R. Arbel-goren, Y. Hadari, S. Eshhar, R. D. Elhanany et al., Galectin-8 Functions as a Matricellular Modulator of Cell Adhesion, Journal of Biological Chemistry, vol.276, issue.33, pp.31285-31295, 2001.
DOI : 10.1074/jbc.M100340200

M. Elola, F. Ferragut, C. Delgado, V. Nugnes, L. Gentilini et al., Expression, localization and function of galectin-8, a tandem-repeat lectin, in human tumors, Histol Histopathol, vol.29, pp.1093-1105, 2014.

S. Nakahara, V. Hogan, H. Inohara, and A. Raz, Importin-mediated Nuclear Translocation of Galectin-3, Journal of Biological Chemistry, vol.281, issue.51, pp.39649-39659, 2006.
DOI : 10.1074/jbc.M608069200

H. Miwa, W. Koba, E. Fine, O. Giricz, P. Kenny et al., Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer, Glycobiology, vol.23, issue.12, pp.1477-1490, 2013.
DOI : 10.1093/glycob/cwt075

P. Jezequel, M. Campone, W. Gouraud, C. Guerin-charbonnel, C. Leux et al., bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer, Breast Cancer Research and Treatment, vol.11, issue.Database Issue, pp.765-775, 2012.
DOI : 10.1007/s10549-011-1457-7

C. Elston and I. Ellis, pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up, Histopathology, vol.9, issue.5, pp.403-410, 1991.
DOI : 10.1016/0277-5379(88)90171-X

M. De-vasconcelos-carvalho, P. Jdos, S. Alves, P. Silveira, E. De-souza et al., Alterations in the immunoexpression of galectins-1, -3 and -7 between different grades of oral epithelial dysplasia, Journal of Oral Pathology & Medicine, vol.270, issue.2, pp.174-179, 2013.
DOI : 10.1111/j.1600-0714.2012.01199.x

J. Jung, H. Kim, J. Yeom, C. Yoo, J. Shin et al., Lowered expression of galectin-2 is associated with lymph node metastasis in gastric cancer, Journal of Gastroenterology, vol.11, issue.1, pp.37-48, 2012.
DOI : 10.1007/s00535-011-0463-1

L. Wang, S. Chen, S. Zhuang, H. Li, and M. Song, Galectin-3 Accelerates the Progression of Oral Tongue Squamous Cell Carcinoma via a Wnt/??-catenin-Dependent Pathway, Pathology & Oncology Research, vol.279, issue.3, pp.461-474, 2013.
DOI : 10.1007/s12253-013-9603-7

D. Tripodi, S. Quemener, K. Renaudin, C. Ferron, O. Malard et al., Gene expression profiling in sinonasal adenocarcinoma, BMC Medical Genomics, vol.55, issue.4, p.65, 2009.
DOI : 10.3322/canjclin.55.4.242
URL : https://hal.archives-ouvertes.fr/inserm-00663564

D. Allred, J. Harvey, M. Berardo, and G. Clark, Prognostic and predictive factors in breast cancer by immunohistochemical analysis, Mod Pathol, vol.11, pp.155-168, 1998.

S. Mohsin, H. Weiss, T. Havighurst, G. Clark, M. Berardo et al., Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study, Modern Pathology, vol.21, issue.12, pp.1545-1554, 2004.
DOI : 10.1038/modpathol.3800229